{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:42:34Z","timestamp":1785307354747,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.vaccine.2022.08.018","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T03:53:50Z","timestamp":1660535630000},"page":"5631-5640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Kinetics of anti-SARS-CoV-2 antibody titer in healthy adults up to 6\u00a0months after BNT162b2 vaccination measured by two immunoassays: A prospective cohort study in Japan"],"prefix":"10.1016","volume":"40","author":[{"given":"Tomoka","family":"Matsuura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wakaba","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Nakagama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutoshi","family":"Kido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Kase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asae","family":"Suita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Komiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiko","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Nitahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayane","family":"Kasamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuko","family":"Nakagami-Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Ohfuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kakeya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.08.018_b0005","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics\u2013developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat Rev Drug Discov"},{"issue":"27","key":"10.1016\/j.vaccine.2022.08.018_b0010","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2022.08.018_b0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.vaccine.2022.08.018_b0020","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jama.2022.0470","article-title":"Association between 3 doses of mRNA COVID-19 Vaccine and symptomatic infection caused by the SARS-CoV-2 Omicron and Delta variants","volume":"327","author":"Accorsi","year":"2022","journal-title":"JAMA"},{"issue":"6576","key":"10.1016\/j.vaccine.2022.08.018_b0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.abm3425","article-title":"Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial","volume":"375","author":"Gilbert","year":"2022","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.vaccine.2022.08.018_b0030","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","article-title":"Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection","volume":"27","author":"Feng","year":"2021","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.vaccine.2022.08.018_b0035","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.018_b0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s15010-020-01503-7","article-title":"A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization","volume":"49","author":"Peterhoff","year":"2021","journal-title":"Infection"},{"issue":"24","key":"10.1016\/j.vaccine.2022.08.018_b0045","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1056\/NEJMoa2114583","article-title":"Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months","volume":"385","author":"Levin","year":"2021","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.vaccine.2022.08.018_b0050","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3390\/vaccines9101125","article-title":"Antibody Persistence 6 Months Post-Vaccination with BNT162b2 among Health Care Workers","volume":"9","author":"Campo","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"9","key":"10.1016\/j.vaccine.2022.08.018_b0055","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S2213-2600(21)00220-4","article-title":"BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers","volume":"9","author":"Lustig","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"9","key":"10.1016\/j.vaccine.2022.08.018_b0060","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3390\/vaccines9091017","article-title":"Comparative immunogenicity of BNT162b2 mRNA vaccine with natural SARS-CoV-2 infection","volume":"9","author":"Psichogiou","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2022.08.018_b0065","doi-asserted-by":"crossref","unstructured":"Kageyama T, Ikeda K, Tanaka S, Taniguchi T, Igari H, Onouchi Y, et al. Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan. Clin Microbiol Infect. 2021; 27: 1861.e1-e5. https:\/\/doi.org\/10.1016\/j.cmi.2021.07.042.","DOI":"10.1016\/j.cmi.2021.07.042"},{"issue":"8","key":"10.1016\/j.vaccine.2022.08.018_b0070","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1111\/ajt.16607","article-title":"Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients","volume":"21","author":"Marinaki","year":"2021","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.vaccine.2022.08.018_b0075","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1001\/jamaoncol.2021.2675","article-title":"Serologic status and toxic effects of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing treatment for cancer","volume":"7","author":"Goshen-Lago","year":"2021","journal-title":"JAMA Oncol"},{"issue":"9","key":"10.1016\/j.vaccine.2022.08.018_b0080","doi-asserted-by":"crossref","first-page":"e2123622","DOI":"10.1001\/jamanetworkopen.2021.23622","article-title":"Evaluation of the SARS-CoV-2 antibody response to the BNT162b2 vaccine in patients undergoing hemodialysis","volume":"4","author":"Yau","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.vaccine.2022.08.018_b0085","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1470-2045(21)00213-8","article-title":"Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study","volume":"22","author":"Monin","year":"2021","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.vaccine.2022.08.018_b0090","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00228-20","article-title":"Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)\/COVID-19 Detection","volume":"34","author":"Safiabadi Tali","year":"2021","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2022.08.018_b0095","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1016\/S2666-5247(21)00266-4","article-title":"WHO International Standard for evaluation of the antibody response to COVID-19 vaccines: call for urgent action by the scientific community","volume":"3","author":"Knezevic","year":"2022","journal-title":"Lancet Microbe"},{"issue":"8","key":"10.1016\/j.vaccine.2022.08.018_b0100","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3390\/vaccines9080840","article-title":"Usefulness of IVD kits for the assessment of SARS-CoV-2 Antibodies to evaluate the humoral response to vaccination","volume":"9","author":"Lukaszuk","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2022.08.018_b0105","doi-asserted-by":"crossref","unstructured":"Perez-Saez J, Zaballa ME, Yerly S, Andrey DO, Meyer B, Eckerle I, et al. Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance. Clin Microbiol Infect. 2021; 27: 1695.e7-e12. https:\/\/doi.org\/10.1016\/j.cmi.2021.06.040.","DOI":"10.1016\/j.cmi.2021.06.040"},{"key":"10.1016\/j.vaccine.2022.08.018_b0110","unstructured":"Abbott ARCHITECT SARS-CoV-2 IgG II Quant Reagent -Instructions for Use- US Food and Drug administration. https:\/\/www.fda.gov\/media\/146371\/download [accessed on 8 February 2022]."},{"key":"10.1016\/j.vaccine.2022.08.018_b0115","unstructured":"Elecsys Anti-CoV-2 S -Instructions for use- US Food and Drug administration. https:\/\/www.fda.gov\/media\/137605\/download [accessed on 8 February 2022]."},{"key":"10.1016\/j.vaccine.2022.08.018_b0120","unstructured":"Japan Society for the Study of Obesity. Guidelines for the management of obesity diseases 2016 (in Japanese). http:\/\/www.jasso.or.jp\/contents\/magazine\/journal.html [accessed on 7 April 2022]."},{"key":"10.1016\/j.vaccine.2022.08.018_b0125","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1016\/j.vaccine.2017.07.062","article-title":"Personalized vaccinology: a review","volume":"36","author":"Poland","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.08.018_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100928","article-title":"Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine","volume":"36","author":"Pellini","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.018_b0135","doi-asserted-by":"crossref","first-page":"e0140221","DOI":"10.1128\/spectrum.01402-21","article-title":"The comparability of anti-spike SARS-CoV-2 antibody tests is time-dependent: a prospective observational study","volume":"10","author":"Perkmann","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"3","key":"10.1016\/j.vaccine.2022.08.018_b0140","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1128\/CVI.00457-09","article-title":"Novel double-antigen sandwich immunoassay for human hepatitis B core antibody","volume":"17","author":"Li","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2022.08.018_b0145","doi-asserted-by":"crossref","first-page":"e0096521","DOI":"10.1128\/Spectrum.00965-21","article-title":"High-resolution linear epitope mapping of the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 mRNA vaccine recipients","volume":"9","author":"Nitahara","year":"2021","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.vaccine.2022.08.018_b0150","doi-asserted-by":"crossref","unstructured":"Perez-Saez J, Zaballa ME, Yerly S, Andrey DO, Meyer B, Eckerle I, et al. Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance. Clin Microbiol Infect. 2021; 27: 1695.e7-e12. https:\/\/doi.org\/10.1016\/j.cmi.2021.06.040.","DOI":"10.1016\/j.cmi.2021.06.040"},{"issue":"2","key":"10.1016\/j.vaccine.2022.08.018_b0155","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.02262-21","article-title":"A dual-antigen SARS-CoV-2 serological assay reflects antibody avidity","volume":"60","author":"Nakagama","year":"2022","journal-title":"J Clin Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2022.08.018_b0160","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.1002\/jmv.27270","article-title":"Vaccination versus infection with SARS-CoV-2: Establishment of a high avidity IgG response versus incomplete avidity maturation","volume":"93","author":"Struck","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2022.08.018_b0165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijid.2021.01.061","article-title":"The potential significance of high avidity immunoglobulin G (IgG) for protective immunity towards SARS-CoV-2","volume":"106","author":"Bauer","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.08.018_b0170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cca.2021.11.023","article-title":"Long-term decay of anti-RBD IgG titers after BNT162b2 vaccination is not mirrored by loss of neutralizing bioactivity against SARS-CoV-2","volume":"524","author":"Malipiero","year":"2022","journal-title":"Clin Chim Acta"},{"issue":"7867","key":"10.1016\/j.vaccine.2022.08.018_b0175","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41586-021-03647-4","article-title":"SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans","volume":"595","author":"Turner","year":"2021","journal-title":"Nature"},{"issue":"7867","key":"10.1016\/j.vaccine.2022.08.018_b0180","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/d41586-021-01557-z","article-title":"A long-term perspective on immunity to COVID","volume":"595","author":"Radbruch","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2022.08.018_b0185","doi-asserted-by":"crossref","unstructured":"Muecksch F, Weisblum Y, Barnes CO, Schmidt F, Schaefer-Babajew D, Wang Z, et al. Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations. Immunity 2021; 54: 1853-1868.e7. https:\/\/doi.org\/10.1016\/j.immuni.2021.07.008.","DOI":"10.1016\/j.immuni.2021.07.008"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22009847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22009847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:14:42Z","timestamp":1759403682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22009847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":37,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0264410X22009847"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.08.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kinetics of anti-SARS-CoV-2 antibody titer in healthy adults up to 6\u00a0months after BNT162b2 vaccination measured by two immunoassays: A prospective cohort study in Japan","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}